マエモンドマコト前門戸任

… Alternative Names

前門戸任マエモンドマコト

Less

Researcher Number	40344676
Other IDs
Affiliation (Current)	2025: 自治医科大学, 医学部, 教授
Affiliation (based on the past Project Information) *help	2025: 自治医科大学, 医学部, 教授 2023: 自治医科大学, 医学部, 教授 2019 – 2022: 岩手医科大学, 医学部, 教授 2013 – 2018: 地方独立行政法人宮城県立病院機構宮城県立がんセンター(研究所), がん先進治療開発研究部, 特任研究員 2017: 岩手医科大学, 医学部, 教授 … More 2012: 地方独立行政法人宮城県立病院機構宮城県立がんセンター(研究所), がん先進治療研究開発部, 特任研究員 2011: 地方独立行政法人宮城県立病院機構宮城県立がんセンター(研究所), がん先進治療開発研究部, 特任研究員 2006 – 2010: Miyagi Cancer Center, Dept.of Respirtory disease, Research Fellow, 免疫学部, 特任研究員 2008: Miyagi Cancer Center Research Institute 2005: 東北大学, 病院, 講師 2003 – 2005: 東北大学, 病院・助手 2004: Tohoku University, Hospital, Research Associate, 病院, 助手 2003: 東北大学, 医学部附属病院, 助手 Less
Review Section/Research Field	Principal Investigator Respiratory organ internal medicine / Basic Section 53030:Respiratory medicine-related / Biological Sciences Except Principal Investigator Respiratory organ internal medicine / Basic Section 53030:Respiratory medicine-related / Respiratory organ internal medicine
Keywords	Principal Investigator 非小細胞肺癌 / EGFR遺伝子変異 / NK4 / EGFR / 癌 / 肺癌 / SLPI / 遺伝子 / 免疫チェックポイント阻害剤 / CMTM6 … More / CMTM4 / CMTM / VEGF / EGFR-TKI / アデノウイルス / 複製可能アデノウイルス / EGFR抗体 / がん / 治療耐性 / エクソソーム / CMTM６ / CMTM４ / CTMT7 / CTMT6 / CTMT4 / 免疫チェックポイント / 分子細胞呼吸器学 / モデルマウス / 分子細胞腫瘍学 / pericyte / Bone marrow derived cell / Tumor angiogenesis / 腫瘍血管新生 / 周皮細胞 / 骨髄由来細胞 / 腫瘍血管 / angiogenesis / gene therapy / adenovirus / HGF / 血管新生 / 遺伝子治療 / 治療法 / 全ゲノムSNP解析 / その他・肺癌 / 呼吸器感染症 / 肺線維症 / 非閉塞性肺疾患癌 / 遺伝子変異 / 血管新生阻害因子 / ウイルス … More Except Principal Investigator SLPI / HGF / サルコイドーシス / 抗腫瘍免疫 / EGFR / 肺癌 / 非小細胞肺癌 / 癌 / 好中球 / 非小細胞肺がん / intracellular signaling / molecular targeting drugs / oncogene addiction / tumorigenesis / anti-apoptotic / bronchiolar epithelial cell / lung adenocarcinoma / EGF receptor / 細胞内シグナル伝達 / 分子標的薬 / がん遺伝子依存 / 発癌 / 不死化 / 細気管支上皮細胞 / 肺腺癌 / EGF受容体 / Lung carcinogenesis / Knockout mouse / Defense system / Tissue regeneration / Tissue repair / Bone marrow derived cells / LPS / 肺発癌 / ノックアウトマウス / 生体防御 / 組織再生 / 組織修復 / 骨髄由来細胞 Less

A cohort study aimed at elucidating the clinical significance of C. acnes in sarcoidosis and classifying its disease types.
- Principal Investigator
  
  澤幡美千瑠
- Project Period (FY)
  2025 – 2028
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  Jichi Medical University
EGFR抗体とEGFR-TKIの二元的アプローチによる抗腫瘍効果とそのメカニズムPrincipal Investigator
- Principal Investigator
  
  前門戸任
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  Jichi Medical University
CMTM family proteins regulate PD-L1 exosome secretion and anti-tumor immunityPrincipal Investigator
- Principal Investigator
  
  前門戸任
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  Jichi Medical University
  Iwate Medical University
CMTMs regulate EGFR mutation positive NSCLCPrincipal Investigator
- Principal Investigator
  
  Maemondo Makto
- Project Period (FY)
  2019 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  Jichi Medical University
  Iwate Medical University
Tumor associated Neutrophils control NSCLC-Immune interface
- Principal Investigator
  
  FUKUHARA TATSURO
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Miyagi Prefectural Hospital Organization Miyagi Cancer Center
Immune escape mediated by the EGFR-derived signal: From Mechanism to TherapyPrincipal Investigator
- Principal Investigator
  
  Mamondo Makoto
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Iwate Medical University
  Miyagi Prefectural Hospital Organization Miyagi Cancer Center
Combining Afatinib and Cetuximab synergistically increases their cytotoxicity for EGFR T790M-harboring cellsPrincipal Investigator
- Principal Investigator
  
  MAEMODNO MAKOTO
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Miyagi Prefectural Hospital Organization Miyagi Cancer Center
Analysis and identify of gene associated with EGFR mutation by gene chip for SNPsPrincipal Investigator
- Principal Investigator
  
  MAEMONDO Makoto
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  地方独立行政法人宮城県立病院機構宮城県立がんセンター(研究所)
  Miyagi Cancer Center Research Institute
SNPに対するジーンチップによる肺癌EGFR変異遺伝子関連遺伝子の発見とその解析Principal Investigator
- Principal Investigator
  
  マエモンドマコト
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Miyagi Cancer Center Research Institute
EGFR変異遺伝子導入による薬剤耐性非小細胞肺癌の高感受性変化Principal Investigator
- Principal Investigator
  
  前門戸任
- Project Period (FY)
  2005
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Tohoku University
Activation mutations in EGF receptor kinase have the advantages of cell physiology in the bronchiolar region : Implication of anti-apoptotic signals and lung tumorigenesis and metastasis.
- Principal Investigator
  
  NUKIWA Toshihiro
- Project Period (FY)
  2005 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  TOHOKU UNIVERSITY
Analyses of inhibitory effect of tumor angiogenesis, targeting the dynamism of bone marrow derived cellsPrincipal Investigator
- Principal Investigator
  
  MAEMONDO Makoto
- Project Period (FY)
  2005 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Miyagi Cancer Center
  Tohoku University
SLPI発現肺癌選択的E1A存在下のNK4蛋白高発現効果:局所並び全身性腫瘍抑制Principal Investigator
- Principal Investigator
  
  前門戸任
- Project Period (FY)
  2003
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Tohoku University
Gene Therapy with SLPI Promoter Controlled Replication-competent Adenovirus for Non-small Cell Lung CancerPrincipal Investigator
- Principal Investigator
  
  MAEMONDO Makoto
- Project Period (FY)
  2003 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  TOHOKU UNIVERSITY
Roles of HGF and SLPI on the pathophysiology in the inflammatory and neoplastic pulmonary lesions : Mechanisms of defense and regeneration and their aberration in these disease statuses.
- Principal Investigator
  
  NUKIWA Toshihiro
- Project Period (FY)
  2002 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Tohoku University

All 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2005 2004 2002

All Journal Article Presentation Book

[Book] ガイドラインには載っていない肺がん Practical Treatment, “EGFR野生型” 肺がんに対するEGFR-TKI治療2014
- Author(s)
  前門戸任
- Publisher
  MEDICAL VIEW社
- Data Source
  KAKENHI-PROJECT-24591184
[Book] Medical Practice M.P, vol.30/No.7 One Point Advice, Do not harm2013
- Author(s)
  前門戸任
- Total Pages
  268
- Publisher
  文光堂
- Data Source
  KAKENHI-PROJECT-24591184
[Journal Article] Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial2019
- Author(s)
  Saito Haruhiro、Fukuhara Tatsuro、Maemondo Makotoら
- Journal Title
  
  The Lancet Oncology
  
  Volume: 20 Issue: 5 Pages: 625-635
- DOI
  10.1016/s1470-2045(19)30035-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K09597
[Journal Article] PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth.2018
- Author(s)
  M Morita, T Sato, M Nomura, Y Sakamoto, Y Inoue, R Tanaka, S Ito, K Kurosawa, K Yamaguchi, Y Sugiura, H Takizaki, Y Yamashita, R Katakura, I Sato, Y Okada, H Watanabe, G Kondoh, et al.
- Journal Title
  
  Cancer Cell
  
  Volume: 12 Issue: 3 Pages: 355-367
- DOI
  10.1016/j.ccell.2018.02.004
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K07296, KAKENHI-PROJECT-16K09597, KAKENHI-PROJECT-16K10486, KAKENHI-PROJECT-17K19620, KAKENHI-PROJECT-17K16876, KAKENHI-PLANNED-25111006, KAKENHI-PROJECT-16H04730, KAKENHI-PROJECT-15K09237, KAKENHI-PROJECT-15K21098, KAKENHI-PROJECT-16K19745, KAKENHI-PROJECT-17K07187, KAKENHI-PUBLICLY-17H05534, KAKENHI-PUBLICLY-17H06011, KAKENHI-PROJECT-16K10774, KAKENHI-PROJECT-17K19606, KAKENHI-PLANNED-17H06301, KAKENHI-PROJECT-16K07187, KAKENHI-PROJECT-17K07231
[Journal Article] Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations.2018
- Author(s)
  Oizumi S, Sugawara S, Minato K, Harada T, Inoue A, Fujita Y, Maemondo M, Watanabe S, Ito K, Gemma A, Demura Y, Fukumoto S, Isobe H, Kinoshita I, Morita S, Kobayashi K, Hagiwara K, Aiba K, Nukiwa T.
- Journal Title
  
  ESMO Open
  
  Volume: 3(2) Issue: 2 Pages: e000313-e000313
- DOI
  10.1136/esmoopen-2017-000313
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09562, KAKENHI-PROJECT-17K09639, KAKENHI-PROJECT-15K09164, KAKENHI-PROJECT-15K09168, KAKENHI-PROJECT-15K09237
[Journal Article] Deficiency of protein-L-isoaspartate (D-aspartate) <i>O</i>-methyl-transferase expression under endoplasmic reticulum stress promotes epithelial mesenchymal transition in lung adenocarcinoma2018
- Author(s)
  Yamashita Masahiro、Ogasawara Masahito、Kawasaki Yasushi、Niisato Miyuki、Saito Heisuke、Kasai Shuya、Maesawa Chihaya、Maemondo Makoto、Yamauchi Kohei
- Journal Title
  
  Oncotarget
  
  Volume: 9 Issue: 17 Pages: 13287-13300
- DOI
  10.18632/oncotarget.24324
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08726, KAKENHI-PROJECT-15K09237, KAKENHI-PROJECT-16K08940, KAKENHI-PROJECT-17K09658
[Journal Article] Distinct Profiles of CD163-Positive Macrophages in Idiopathic Interstitial Pneumonias2018
- Author(s)
  Yamashita M, Saito R, Yasuhira S, Fukuda Y, Sasamo H, Sugai T, Yamauchi K, Maemondo M
- Journal Title
  
  J Immunol Res
  
  Volume: 2018 Pages: 1436236-1436236
- DOI
  10.1155/2018/1436236
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K08940, KAKENHI-PROJECT-15K09237, KAKENHI-PROJECT-17K08700
[Journal Article] Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)2017
- Author(s)
  Nokihara H
- Journal Title
  
  Ann Oncol
  
  Volume: 28 Issue: 11 Pages: 2698-2706
- DOI
  10.1093/annonc/mdx419
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K09226, KAKENHI-PROJECT-15K09237
[Journal Article] EGFR Mutation Analysis of Circulating Tumor DNA Using an Improved PNA-LNA PCR Clamp Method2016
- Author(s)
  Watanabe K, Fukuhara T, Tsukita Y, Morita M, Suzuki A, Tanaka N, Terasaki H, Nukiwa T, Maemondo M
- Journal Title
  
  Can Respir J.
  
  Volume: 5297329 Pages: 1-6
- DOI
  10.1155/2016/5297329
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-15K14414, KAKENHI-PROJECT-16K09597, KAKENHI-PROJECT-15K09237
[Journal Article] Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 07022015
- Author(s)
  .Inoue A, Sugawara S, Maemondo M, Mori Y, Oizumi S, Harada M, Taima K, Morikawa N, Ishida T, Kinoshita I, Watanabe H, Suzuki T, Nakagawa T, Saito R, Nukiwa T
- Journal Title
  
  Lung Cancer
  
  Volume: 89 Issue: 1 Pages: 61-5
- DOI
  10.1016/j.lungcan.2015.04.012
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K09164, KAKENHI-PROJECT-15K09237
[Journal Article] Factors associated with a poor response to gefitinib in the NEJ002 study: Smoking and the L858R mutation.2015
- Author(s)
  Fukuhara T, Yoshizawa H et al.
- Journal Title
  
  Lung Cancer
  
  Volume: 88 Issue: 2 Pages: 181-6
- DOI
  10.1016/j.lungcan.2015.02.004
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-25461172, KAKENHI-PROJECT-26461175, KAKENHI-PROJECT-15K09164, KAKENHI-PROJECT-15K09237, KAKENHI-PROJECT-15K15320
[Journal Article] The role of smoking status on the progression-free survival of non-small-cell lung cancer patients harboring activating epidermal growth factor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor: a meta-analysis of prospective randomized trials.2015
- Author(s)
  Hasegawa Y, Ando M, Maemondo M, Yamamoto S, Isa S, Saka H, Kubo A, Kawaguchi T, Takada M, Rosell R, Kurata T, Ou SH.
- Journal Title
  
  The Oncologist
  
  Volume: 20 Issue: 3 Pages: 1-9
- DOI
  10.1634/theoncologist.2014-0285
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501314, KAKENHI-PROJECT-15K09237, KAKENHI-PROJECT-25460896
[Journal Article] Loss of protein phosphatase 6 in mouse keratinocytes increases susceptibility to ultraviolet-B-induced carcinogenesis.2015
- Author(s)
  Kato H, Kurosawa K, Inoue Y, Tanuma N, Momoi Y, Hayashi K, Ogoh H, Nomura M, Sakayori M, Kakugawa Y, Yamashita Y, Miura K, Maemondo M, Katakura R, Ito S, Sato M, Sato I, Chiba N, Watanabe T, Shima H.
- Journal Title
  
  Cancer Lett.
  
  Volume: 365 Issue: 2 Pages: 223-228
- DOI
  10.1016/j.canlet.2015.05.022
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-15K09237, KAKENHI-PROJECT-15K10081, KAKENHI-PROJECT-26430130, KAKENHI-PROJECT-26461967, KAKENHI-PROJECT-15K14387, KAKENHI-PROJECT-15K19081, KAKENHI-PROJECT-15K20237, KAKENHI-PROJECT-25430163, KAKENHI-PROJECT-25670609
[Journal Article] Synergistic cytotoxicity of afatinib and cetuximab against EGFR T790M involves Rab11-dependent EGFR recycling.2014
- Author(s)
  Watanuki, Z.Kosai, H., Osanai, N., Ogama, N., Mochizuki, M., Tamai, K., Yamaguchi, K., Satoh, K., Fukuhara, T., Maemondo, M., Ichinose, M., Nukiwa, T., Tanaka, N.
- Journal Title
  
  Biochem Biophy Res Commun
  
  Volume: 455 Issue: 3-4 Pages: 269-276
- DOI
  10.1016/j.bbrc.2014.11.003
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24300326, KAKENHI-PROJECT-24591184, KAKENHI-PROJECT-24592613
[Journal Article] Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study.2014
- Author(s)
  Seto T, Kato T, Nishio M, Goto K, Atagi S, Hosomi Y, Yamamoto N, Hida T, Maemondo M, Nakagawa K, Nagase S, Okamoto I, Yamanaka T, Tajima K, Harada R, Fukuoka M, Yamamoto N.
- Journal Title
  
  Lancet Oncol.
  
  Volume: 15 Issue: 11 Pages: 1236-1244
- DOI
  10.1016/s1470-2045(14)70381-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591184
[Journal Article] A phase II study of erlotinib monotherapy in pre-treated non-small cell lung cancer without EGFR gene mutation who have never/light smoking history: Re-evaluation of EGFR gene status (NEJ006/TCOG0903)2014
- Author(s)
  Matsumoto Y, Maemondo M, Ishii Y, Okudera K, Demura Y, Takamura K, Kobayashi K, Morikawa N, Gemma A, Ishimoto O, Usui K, Harada M, Miura S, Fujita Y, Sato I, Saijo Y;
- Journal Title
  
  Lung Cancer
  
  Volume: 86 Issue: 2 Pages: 195-200
- DOI
  10.1016/j.lungcan.2014.08.019
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24591184, KAKENHI-PROJECT-25461172
[Journal Article] Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer: North Japan Lung Cancer Group Trial 08022014
- Author(s)
  Kawashima Y, Inoue A, Sugawara S, Oizumi S, Maemondo M, Okudera K, Suzuki T, Usui K, Harada M, Morikawa N, Hasegawa Y, Saito R, Ishimoto O, Sakakibara T, Asahina H, Nukiwa T.
- Journal Title
  
  Respir Investig.
  
  Volume: 52 Issue: 3 Pages: 190-194
- DOI
  10.1016/j.resinv.2013.12.005
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591184
[Journal Article] An activation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosine kinase inhibitors in lung adenocarcinoma2014
- Author(s)
  Nihira K, Miki Y, Iida S, Narumi S, Ono K, Iwabuchi E, Ise K, Mori K, Saito M, Ebina M, Sato I, Maemondo M, Yamada-Okabe H, Kondo T, Sasano H. An activation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosine kinase inhibitors in lung adenocarcinoma.
- Journal Title
  
  J Pathol
  
  Volume: 234 Issue: 2 Pages: 277-288
- DOI
  10.1002/path.4354
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24591184
[Journal Article] Randomized Phase II Trial Comparing Carboplatin Plus Weekly Paclitaxel and Docetaxel Alone in Elderly Patients With Advanced Non-Small Cell Lung Cancer: North Japan Lung Cancer Group Trial 08012014
- Author(s)
  Maemondo M, Inoue A, Sugawara S, Harada T, Minegishi Y, Usui K, Miwa K, Morikawa N, Kambe M, Ube K, Watanabe K, Ishimoto O, Sakakibara T, Gemma A, Nukiwa T
- Journal Title
  
  Oncologist
  
  Volume: 19 Issue: 4 Pages: 352-353
- DOI
  10.1634/theoncologist.2013-0411
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591184, KAKENHI-PROJECT-25461145, KAKENHI-PROJECT-25461172
[Journal Article] Cigarette smoking and lung cancer risk according to histological type in Japanese men and women.2013
- Author(s)
  Seki T, Takahashi S, et al.
- Journal Title
  
  Cancer Sci
  
  Volume: 104 Issue: 11 Pages: 1515-1522
- DOI
  10.1111/cas.12273
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23390179, KAKENHI-PROJECT-24591184, KAKENHI-PROJECT-24591928
[Journal Article] Updated Overall Survival Results from A Randomized Phase III Trial Comparing Gefitinib with Carboplatin-Paclitaxel for Chemo-Naive Non-Small Cell Lung Cancer with Sensitive EGFR Gene Mutations (NEJ002)2013
- Author(s)
  Inoue A, Kobayashi K, Maemondo M, et al
- Journal Title
  
  Ann Oncol
  
  Volume: 24 Issue: 1 Pages: 54-9
- DOI
  10.1093/annonc/mds214
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790746, KAKENHI-PROJECT-23591132, KAKENHI-PROJECT-24240042, KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-24591184, KAKENHI-PROJECT-24659396
[Journal Article] A prospective, phase II, open-label study (JO22903) of first-line erlotinib in Japanese patients with epidermal growth factor receptor (EGFR) mutation-positive advanced non-small-cell lung cancer (NSCLC)2013
- Author(s)
  3 ) Goto K, Nishio M, Yamamoto N, Chikamori K, Hida T, Maemondo M, Katakami N, Kozuki T, Yoshioka H, Seto T, Fukuyama T, Tamura T
- Journal Title
  
  Lung Cancer
  
  Volume: vol.82 Issue: 1 Pages: 109-114
- DOI
  10.1016/j.lungcan.2013.07.003
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591184
[Journal Article]2012
- Author(s)
  Soda M, Isobe K, Inoue A, Maemondo M,Oizumi S, Fujita Y, Gemma A, Yamashita Y,Ueno T, Takeuchi K, Choi YL, Miyazawa H,Tanaka T, Hagiwara K, Mano H
- Journal Title
  
  Clin Cancer Res
  
  Volume: 18 Issue: 20 Pages: 5682-5689
- DOI
  10.1158/1078-0432.ccr-11-2947
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22300326, KAKENHI-PROJECT-22680063, KAKENHI-PROJECT-22790746, KAKENHI-PROJECT-23689043, KAKENHI-PROJECT-24591184
[Journal Article] Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer : Quality of Life Analysis of North East Japan Study Group 002 Trial2012
- Author(s)
  Oizumi S, Kobayashi K, Inoue A, Maemondo M, Sugawara S, Yoshizawa H, Isobe H, Harada M, Kinoshita I, Okinaga S, Kato T, Harada T, Gemma A, Saijo Y, Yokomizo Y, Morita S, Hagiwara K, Nukiwa T.
- Journal Title
  
  Oncologist
  
  Volume: 17 Issue: 6 Pages: 863-70
- DOI
  10.1634/theoncologist.2011-0426
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591006, KAKENHI-PROJECT-22790746, KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-24591184, KAKENHI-PROJECT-24659396
[Journal Article] Runx1-deficiency in CD4+ T Cells Causes Fatal Autoimmune Inflammatory Lung Disease due to Spontaneous Hyperactivation of Cells2012
- Author(s)
  Wong WF
- Journal Title
  
  J. Immunol.
  
  Volume: 188 Issue: 10 Pages: 5408-5420
- DOI
  10.1038/bjc.2012.422
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390164, KAKENHI-PROJECT-22790746, KAKENHI-PROJECT-24591184, KAKENHI-PROJECT-24592826
[Journal Article] Low-dose gefitinib treatment for patients with advanced non-small cell lung cancer harboring sensitive epidermal growth factor receptor mutations2011
- Author(s)
  Satoh H, Inoue A, Kobayashi K, Maemondo M, et al
- Journal Title
  
  J Thorac Oncol
  
  Volume: 8 Pages: 160-168
- Data Source
  KAKENHI-PROJECT-21591012
[Journal Article] EGFR遺伝子変異による個別化医療に向けた治療戦略2011
- Author(s)
  前門戸任
- Journal Title
  
  分子呼吸器病
  
  Volume: 3/1号 Pages: 45-47
- Data Source
  KAKENHI-PROJECT-21591012
[Journal Article] Gefitinib or chemotherapy for non-small cell lung cancer with mutated EGFR.2010
- Author(s)
  Maemondo M, Inoue A, Kobayashi K, et al
- Journal Title
  
  N Engl J Med.
  
  Volume: 362(25) Pages: 2380-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591012
[Journal Article] A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer : North Japan Lung Cancer Study Group Trial 04052010
- Author(s)
  Inoue A, Ishimoto O, Fukumoto S, Maemondo M, et al
- Journal Title
  
  Ann Oncol.
  
  Volume: 21(4) Pages: 800-3
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591012
[Journal Article] First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy2009
- Author(s)
  Inoue A, Kobayashi K, Usui K, Maemondo M, et al
- Journal Title
  
  J Clin Oncol. 27(9)巻
  
  Pages: 1394-1400
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591012
[Journal Article] A phase II study of palonosetron combined with dexamethasone toprevent nausea andvomiting induced by highly emetogenic chemotherapy2009
- Author(s)
  Maemondo M, Masuds N, Sekine I, Kubota K, et al
- Journal Title
  
  Ann Oncol. 20(11)巻
  
  Pages: 1860-1866
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591012
[Journal Article] Analyses of effect of NK4 on tumor angiogenesis through recruitment of bone marrow derived cells2005
- Author(s)
  Okouchi S, Maemondo M, Toshiaki K, Tazawa R, Saijo Y, Nukiwa T.
- Journal Title
  
  Nihon kokyuukigakkai zashi 43
  
  Pages: 275-275
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17590776
[Journal Article] Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.2004
- Author(s)
  Maemondo M. et al.
- Journal Title
  
  Cancer Res 64
  
  Pages: 4611-4620
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15590793
[Journal Article] Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.2004
- Author(s)
  Maemondo M. et al.
- Journal Title
  
  Cancer Res. 64
  
  Pages: 4611-4620
- Data Source
  KAKENHI-PROJECT-14207027
[Journal Article] Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.2004
- Author(s)
  Maemondo M, et al.
- Journal Title
  
  Cancer Res 64
  
  Pages: 4611-4620
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-14207027
[Journal Article] Gene therapy with secretory leukoprotease inhibitor promoter-controlled eplication-competent adenovirus for non-small cell lung cancer.2004
- Author(s)
  Maemondo M. et al.
- Journal Title
  
  Cancer Res 64
  
  Pages: 4611-4620
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15590793
[Journal Article] Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.2004
- Author(s)
  Maemondo M.et al.
- Journal Title
  
  Cancer Res 64
  
  Pages: 4611-4620
- Data Source
  KAKENHI-PROJECT-15590793
[Journal Article] Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy.2002
- Author(s)
  Maemondo M, et al.
- Journal Title
  
  Mol Ther 5
  
  Pages: 177-185
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-14207027
[Journal Article] Targeting angiogenesis and HGF function using an adenoviral vectorexpressing the HGF antagonist NK4 for cancer therapy.2002
- Author(s)
  Maemondo M, et al.
- Journal Title
  
  Mol Ther 5
  
  Pages: 177-185
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-14207027
[Presentation] 高感度EGFR遺伝子変異解析を用いた非小細胞肺癌血漿中循環DNAの測定2015
- Author(s)
  渡邉香奈、福原達郎、突田容子、盛田麻美、鈴木綾、寺崎浩司、前門戸任
- Organizer
  第55回日本呼吸器学会学術講演会
- Place of Presentation
  東京
- Year and Date
  2015-04-17
- Data Source
  KAKENHI-PROJECT-15K09237
[Presentation] alectinib耐性後にc-Met遺伝子増幅を来しcrizotinibが奏効したALK融合遺伝子陽性肺腺癌の一例,2015
- Author(s)
  渡邉香奈、突田容子、盛田麻美、鈴木綾、福原達朗、玉井恵一、片山量平、前門戸任
- Organizer
  第５６回日本肺癌学会学術集会
- Place of Presentation
  横浜市
- Year and Date
  2015-11-26
- Data Source
  KAKENHI-PROJECT-15K09237
[Presentation] Randomized phase 2 trial comparing amrubicin (A) with re-challenge of platinum doublet (P) in patients (pts) with sensitive-relapsed small-cell lung cancer (SCLC).2014
- Author(s)
  Atsushi Nakamura, Akira Inoue, Makoto Maemondo, Yoshiaki Mori, Satoshi Oizumi, Masao Harada, Shingo Takanashi, Naoto Morikawa, Takashi Ishida, Ichiro Kinoshita, Hiroshi Watanabe, Toshiro Suzuki, Taku Nakagawa, Ryota Saito, Toshihiro Nukiwa
- Organizer
  2014 ASCO annual meeting
- Place of Presentation
  Chicago, IL, USA
- Year and Date
  2014-05-30
- Data Source
  KAKENHI-PROJECT-24591184
[Presentation] Randomized phase 2 study of carboplatin plus irinotecan (CI) versus carboplatin plus amrubicin (CA) for extensive disease small-cell lung cancer (ED-SCLC): NJLCG09012014
- Author(s)
  Yosuke Kawashima, Naoto Morikawa, Shunichi Sugawara, Makoto Maemondo, Toshiyuki Harada, Masao Harada, Akira Inoue, Yuka Fujita, Terufumi Kato, Hiroshi Yokouchi, Hiroshi Watanabe, Kazuhiro Usui, Toshiro Suzuki, Satoshi Oizumi, Hiroki Nagai, Mariko Kanbe, Toshihiro Nukiwa
- Organizer
  2014 ASCO annual meeting
- Place of Presentation
  Chicago, IL, USA
- Year and Date
  2014-05-30
- Data Source
  KAKENHI-PROJECT-24591184
[Presentation] North East Japan Study Group/The Tokyo Cooperative Oncology Group; Randomized phase II study of concurrent gefitinib and chemotherapy versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer (NSCLC) with sensitive EGFR mutations: NEJ005/TCOG0902.2014
- Author(s)
  Satoshi Oizumi, Shunichi Sugawara, Koichi Minato, Toshiyuki Harada, Akira Inoue, Yuka Fujita, Makoto Maemondo, Hirohisa Yoshizawa, Kazuhiko Ito, Akihiko Gemma, Masaru Nishitsuji, Masao Harada, Hiroshi Isobe, Ichiro Kinoshita, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Minoru Kurihara, Toshihiro Nukiwa
- Organizer
  2014 ASCO annual meeting
- Place of Presentation
  Chicago, IL, USA
- Year and Date
  2014-05-30
- Data Source
  KAKENHI-PROJECT-24591184
[Presentation] Erlotinib plus bevacizumab (EB) versus erlotinib alone (E) as first-line treatment for advanced EGFR mutation–positive nonsquamous non-small cell lung cancer (NSCLC): An open-label randomized trial2014
- Author(s)
  Terufumi Kato, Takashi Seto, Makoto Nishio, Koichi Goto, Shinji Atagi, Yukio Hosomi, Noboru Yamamoto, Toyoaki Hida, Makoto Maemondo, Kazuhiko Nakagawa, Seisuke Nagase, Isamu Okamoto, Takeharu Yamanaka, Ryosuke Harada, Masahiro Fukuoka, Nobuyuki Yamamoto
- Organizer
  2014 ASCO annual meeting
- Place of Presentation
  Chicago, IL, USA
- Year and Date
  2014-05-30
- Data Source
  KAKENHI-PROJECT-24591184
[Presentation] Phase II study of S-1 plus irinotecan for EGFR-mutated non-small cell lung cancer (NSCLC) resistant to both platinum-based chemotherapy and EGFR-TKI: NJLCG08042013
- Author(s)
  Akira Inoue, Shunichi Sugawara, Masao Harada, Makoto Maemondo, Toshiyuki Harada, Kunihiko Kobayashi, Osamu Ishimoto, Shinichi Fukumoto, Nobumichi Matsubara, Tetsuya Okano, Toshihiro Nukiwa
- Organizer
  15th World Conference on Lung Cancer
- Place of Presentation
  Sydney Australia
- Data Source
  KAKENHI-PROJECT-24591184
[Presentation] Phase II study of combination therapy with S-1 and irinotecan in EGFR-mutated non-small cell lung cancer (NSCLC) resistant to both platinum-based chemotherapy and EGFR-TKI: NJLCG08042013
- Author(s)
  Maemondo M, Sugawara S, Harada T, Fukumoto S, Inoue A, Ishimoto O, Matsubara N, Harada M, Kobayashi K, Nukiwa T
- Organizer
  The European Cancer Congress 2013
- Place of Presentation
  Amsterdam
- Data Source
  KAKENHI-PROJECT-24591184
[Presentation] North Japan Lung Cancer Group 08032013
- Author(s)
  Shoichi Kuyama, Akira Inoue, Masamoto Nakanishi, Yosuke Kawashima, Masao Harada, Kunihiko Kobayashi, Toshiyuki Kozuki, Tomohiro Sakakibara, Makoto Maemondo, Hajime Asahina, Akiko Hisamoto, Taku Nakagawa
- Organizer
  15th World Conference on Lung Cancer
- Place of Presentation
  Sydney Australia
- Data Source
  KAKENHI-PROJECT-24591184
[Presentation] Variability of epidermal growth factor receptor (EGFR) mutations in serum during erlotinib therapy and its clinical implications: exploratory analysis of a phase II study of erlotinib in patients with advanced non-small-cell lung cancer (NSCLC) harboring2013
- Author(s)
  Makoto Maemondo, Makoto Nishio, Noboru Yamamoto, Kenichi Chikamori, Nobuyuki Katakami, Toyoaki Hida, Takashi Seto, Hiroshige Yoshioka, Toshiyuki Kozuki, Norihisa Ohishi, Tomohide Tamura
- Organizer
  15th World Conference on Lung Cancer
- Place of Presentation
  Sydney Australia
- Data Source
  KAKENHI-PROJECT-24591184
[Presentation] Phase II study of amrubicin (AMR) and carboplatin (CBDCA) for invasive thymoma (IT) and thymic carcinoma (TC): NJLCG0803.　J Clin Oncol 31, 2013 (suppl; abstr 7530)2013
- Author(s)
  Yosuke Kawashima, Akira Inoue, Shunichi Sugawara, Masao Harada, Kunihiko Kobayashi, Toshiyuki Kozuki, Shoichi Kuyama, Tomohiro Sakakibara, Makoto Maemondo, Hajime Asahina, Akiko Hisamoto, Taku Nakagawa, Toshihiro Nukiwa
- Organizer
  49th ASCO Annual Meeting
- Place of Presentation
  CHICAGO
- Data Source
  KAKENHI-PROJECT-24591184
[Presentation] A Case of Small Cell Lung Cancer with Cancer-Associated Retinopathy (CAR) Accompanied by Circulating Anti-CRMP5/CV2 Antibodies2013
- Author(s)
  Mami Morita, Tatsuro Fukuhara, Yoko Tsukita, Zenta Watanuki, Aya Suzuki, Kana Watanabe, Nobuyuki Sato, Hidetoshi Takahashi, Shigemi Ito, Ikuro Sato, and Makoto Maemondo,
- Organizer
  18th Congress of the Asian Pacific Society of Respirology
- Place of Presentation
  横浜市
- Data Source
  KAKENHI-PROJECT-24591184
[Presentation] One-year follow-up of a Phase I/II study of a highly selective ALK inhibitor CH5424802/RO5424802 in ALK-rearranged advanced non-small cell lung cancer (NSCLC) North Japan Lung Cancer Group 08032013
- Author(s)
  Akira Inoue, Makoto Nishio, Katsuyuki Kiura, Takashi Seto, Kazuhiko Nakagawa, Makoto Maemondo, Toyoaki Hida, Hiroshige Yoshioka, Masao Harada, Yuichiro Ohe, Naoyuki Nogami, Haruyasu Murakami, Kengo Takeuchi, Kazue Kikuchi, Takashi Asakawa, Shumpei Yokoyama, Tomohide Tamura
- Organizer
  15th World Conference on Lung Cancer
- Place of Presentation
  Sydney Australia
- Data Source
  KAKENHI-PROJECT-24591184
[Presentation] A phase I/II study with a highly selective ALK inhibitor CH5424802 in ALK-positive non-small cell lung cancer (NSCLC) patients: Updated safety and efficacy results from AF-001JP. J Clin Oncol 31, 2013 (suppl; abstr 8033)2013
- Author(s)
  Kazuhiko Nakagawa, Katsuyuki Kiura, Makoto Nishio, Takashi Seto, Makoto Maemondo, Akira Inoue, Toyoaki Hida, Nobuyuki Yamamoto, Hiroshige Yoshioka, Masao Harada, Yuichiro Ohe, Naoyuki Nogami, Kengo Takeuchi, Tadashi Shimada, Tomohiro Tanaka, Tomohide Tamura
- Organizer
  49th ASCO Annual Meeting
- Place of Presentation
  CHICAGO
- Data Source
  KAKENHI-PROJECT-24591184
[Presentation] A phase ll study of erlotinib monotherpay in previously treated advanced non-small cell lung cancer(NSCLC) without EGFR gene mutation who have never/light smoking history2012
- Author(s)
  Maemondo M
- Organizer
  ESMO
- Place of Presentation
  Australia
- Data Source
  KAKENHI-PROJECT-24591184
[Presentation] Final analysis of randomized phase ll trial of carboplatin combined with weekly paclitaxel(CP) and docetaxel alone(D) in elderly patients(pts) with advanced non-small cell lung cancer(NSCLC):2012
- Author(s)
  Maemondo M
- Organizer
  ESMO
- Place of Presentation
  Australia
- Data Source
  KAKENHI-PROJECT-24591184
[Presentation] Gefitinib for the lung tumors with mutated EGFR2011
- Author(s)
  Makoto Maemondo
- Organizer
  European Respiratory Society(招待講演)
- Place of Presentation
  Amsterdam Netherland
- Year and Date
  2011-09-27
- Data Source
  KAKENHI-PROJECT-21591012
[Presentation] Gefitinib for the lung tumors with mutated EGFR2011
- Author(s)
  Makoto Maemondo
- Organizer
  European Respiratory Society
- Place of Presentation
  Amsterdam Netherland(招待講演)
- Year and Date
  2011-09-27
- Data Source
  KAKENHI-PROJECT-21591012
[Presentation] Gefitinib for the lung tumors with mutated EGFR2011
- Author(s)
  Makoto Maemondo
- Organizer
  KASLC
- Place of Presentation
  Seoul Korea(招待講演)
- Year and Date
  2011-11-18
- Data Source
  KAKENHI-PROJECT-21591012
[Presentation] Gefitinib for the lung tumors with mutated EGFR2011
- Author(s)
  Makoto Maemondo
- Organizer
  KASLC(招待講演)
- Place of Presentation
  Seoul Korea
- Year and Date
  2011-11-18
- Data Source
  KAKENHI-PROJECT-21591012
[Presentation] Final overall survival results of NEJ002, a phase III trial comparing gefitinib to carboplatin (CBDCA) Plus paclitaxel (TXL) as the first-line treatment for advanced non-small cell lung cancer (NSCLC) with EGFR mutations2011
- Author(s)
  A.Inoue, K.Kobayashi, M.Maemondo, et al
- Organizer
  ASCO Annual Meeting
- Place of Presentation
  Chicago
- Year and Date
  2011-06-06
- Data Source
  KAKENHI-PROJECT-21591012
[Presentation] Final overall survival results of NEJ002, a phase III trial comparing gefitinib to carboplatin(CBDCA) Plus paclitaxel(TXL) as the first-line treatment for advanced non-small cell lung cancer(NSCLC) with EGFR mutations2011
- Author(s)
  A. Inoue, K. Kobayashi, M. Maemondo, et al
- Organizer
  ASCO Annual Meeting
- Place of Presentation
  Chicago
- Year and Date
  2011-06-06
- Data Source
  KAKENHI-PROJECT-21591012

1. TANAKA Nobuyuki (60280872)

# of Collaborated Projects: 5 results

# of Collaborated Products: 3 results
2. ハギワラコウイチ (00240705)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
3. NUKIWA Toshihiro (40129036)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. SAIJO Yasuo (10270828)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
5. SUZUKI Takuji (80344670)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
6. FUKUHARA Tatsuro (80400365)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
7. EBINA Masahito (10280885)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. KIKUCHI Toshiaki (10280926)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. INOUE Akira (70361087)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
10. NISHIO Kazuto (10208134)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. KANEHIRA Masahiko (90374941)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 長島隆一 (20783707)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 澤幡美千瑠 (00812629)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 江石義信 (70151959)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. 片山量平 (60435542)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. YAMAGUCHI Kazunori

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
17. TAMAI Keiichi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
18. OIZUMI Satoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
19. INOUE Kenich

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
20. GENMA Akihiko

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
21. YOSHIZAWA Hirohisa

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
22. KUBO Akihito

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
23. TAKADA Minoru

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
24. KAWAGUCHI Tomoya

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
25. ISA Shun-Ichi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
26. 小鎌直子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
27. 渡辺利雄

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
28. 小林国彦

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
29. 前沢千早

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
30. 山下雅大

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

マエモンド マコト 前門戸 任

前門戸 任 マエモンド マコト

Research Projects

Research Products

Co-Researchers

A cohort study aimed at elucidating the clinical significance of C. acnes in sarcoidosis and classifying its disease types.

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

EGFR抗体とEGFR-TKIの二元的アプローチによる抗腫瘍効果とそのメカニズムPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

CMTM family proteins regulate PD-L1 exosome secretion and anti-tumor immunityPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

CMTMs regulate EGFR mutation positive NSCLCPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Tumor associated Neutrophils control NSCLC-Immune interface

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Immune escape mediated by the EGFR-derived signal: From Mechanism to TherapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Combining Afatinib and Cetuximab synergistically increases their cytotoxicity for EGFR T790M-harboring cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis and identify of gene associated with EGFR mutation by gene chip for SNPsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

SNPに対するジーンチップによる肺癌EGFR変異遺伝子関連遺伝子の発見とその解析Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

EGFR変異遺伝子導入による薬剤耐性非小細胞肺癌の高感受性変化Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Activation mutations in EGF receptor kinase have the advantages of cell physiology in the bronchiolar region : Implication of anti-apoptotic signals and lung tumorigenesis and metastasis.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analyses of inhibitory effect of tumor angiogenesis, targeting the dynamism of bone marrow derived cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

SLPI発現肺癌選択的E1A存在下のNK4蛋白高発現効果:局所並び全身性腫瘍抑制Principal Investigator

Principal Investigator

Project Period (FY)

マエモンドマコト前門戸任

前門戸任マエモンドマコト